Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ioannis Natsiopoulos
Observed names:
I Natsiopoulos,
I. Natsiopoulos,
IOANNIS NATSIOPOULOS
Institution:
Interbalkan Medical Center
Observed institutions:
Interbalkan Medical Center,
Papageorgiou General Hospital,
Hellenic Cooperative Oncology Group,
G. Papanikolaou General Hospital
OpenAlex ID:
A5049167906
Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment
2019
·
Ioannis Natsiopoulos
, Stavros Intzes
, et al.
·
Clinical Breast Cancer
·
79
Prognostic Significance of Low HER2 Expression in Patients With Early Hormone Receptor Positive Breast Cancer
2022
·
GEORGE DOUGANIOTIS
, LOUKAS KONTOVINIS
, et al.
·
Cancer Diagnosis & Prognosis
·
38
Metaplastic Breast Carcinoma in a Patient with Von Recklinghausen's Disease
2007
·
Ioannis Natsiopoulos
, Aristides Chatzichristou
, et al.
·
Clinical Breast Cancer
·
22
Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center
2017
·
Angela Apessos
, Konstantinos Agiannitopoulos
, et al.
·
Cancer Genetics
·
20
Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease—a prospective study
2008
·
Stavros A. Antoniou
, Panagiotis Delivorias
, et al.
·
Langenbeck s Archives of Surgery
·
19
Becker Expander-Based Breast Reconstruction Following Wise Pattern Skin-Reducing Mastectomy: Complication Rates and Risk Factors
2017
·
E. Demiri
, D. Dionyssiou
, et al.
·
Aesthetic Plastic Surgery
·
18
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing
2023
·
KONSTANTINOS AGIANNITOPOULOS
, GEORGIA PEPE
, et al.
·
Cancer Genomics & Proteomics
·
16
PDF
Targeted axillary dissection: worldwide variations in clinical practice
2024
·
Michalis Kontos
, Prodromos Kanavidis
, et al.
·
Breast Cancer Research and Treatment
·
15
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
2023
·
Konstantinos Agiannitopoulos
, Kevisa Potska
, et al.
·
Cancers
·
14
PDF
Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer
2021
·
KONSTANTINOS AGIANNITOPOULOS
, GEORGIA PEPE
, et al.
·
Cancer Genomics & Proteomics
·
12
PDF
The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory
2024
·
NIKOLAOS TSOULOS
, KONSTANTINOS AGIANNITOPOULOS
, et al.
·
Cancer Genomics & Proteomics
·
10
Diffuse Breast Angiomatosis With Involvement of Overlying Skin: A Case Report
2015
·
Ioannis Natsiopoulos
, Triantafyllos Liappis
, et al.
·
Clinical Breast Cancer
·
8
Association of Oncotype-DX HER2 Single Gene Score With HER2 Expression Assessed by Immunohistochemistry in HER2-low Breast Cancer
2024
·
GEORGE DOUGANIOTIS
, LOUKAS KONTOVINIS
, et al.
·
Cancer Diagnosis & Prognosis
·
4
PDF
Real-world experience of neoadjuvant chemotherapy for early breast cancer patients: an observational non-interventional study in Thessaloniki, Greece.
2020
·
Konstantinos T Papazisis
, Triantafyllos Liappis
, et al.
·
PubMed
·
3
Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) –A phase II study
2004
·
D. Tsavdaridis
, A. Athanasiadis
, et al.
·
Journal of Clinical Oncology
·
3
The Role of the NOLUS Score in Predicting pCR and iDFS in HR-positive HER2-negative Early Breast Cancer Patients who Received Neoadjuvant Chemotherapy
2024
·
ANNA-LEA AMYLIDI
, LOUKAS KONTOVINIS
, et al.
·
Cancer Diagnosis & Prognosis
·
2
PDF
The role of PIK3CA mutation in lobular breast cancer in the era of precision oncology – A systematic review
2025
·
Christos Kavazis
, Anastasia Ekmektzoglou
, et al.
·
Critical Reviews in Oncology/Hematology
·
1
Abstract P1-03-08: Different genomic rearrangements account for 17% of BRCA1/2 mutations in Greece
2015
·
Angela Apessos
, Eirini Papadopoulou
, et al.
·
Cancer Research
·
1
Abstract PS3-05-05: High-risk cancer susceptibility genes mutation carriers’ compliance with surgical risk reduction for breast and ovarian cancer
2026
·
K. Papazisis
, M. Paraskeva
, et al.
·
Clinical Cancer Research
3053eP High-risk cancer susceptibility genes mutation carriers’ compliance with surgical risk reduction for breast and ovarian cancer
2025
·
K. Papazisis
, M. Paraskeva
, et al.
·
Annals of Oncology
PDF
Abstract P4-07-30: The prognostic and predictive value of Oncotype DX® in ER+/HER2-/pT2N0, cM0 Breast Cancer Patients
2025
·
Ioannis Natsiopoulos
, Venizelos Vasileios
, et al.
·
Clinical Cancer Research
Abstract P4-09-29: PR status cannot predict Oncotype DX Recurrence Score®: a study in a Greek cohort of N0M0/ER+/PR-/HER2- breast cancer patients tested with Oncotype DX
2025
·
Vasileios Venizelos
, Rodoniki Iosifidou
, et al.
·
Clinical Cancer Research
63P Predicting oncotype-dx outcomes in resource-limited settings: The role of NOLUS immunohistochemical score
2025
·
A.L. Amylidi
, G. Douganiotis
, et al.
·
ESMO Open
P113: Li-Fraumeni: “Genetic testing of Breast/ovarian cancer patients unmask familial pathogenic germline variants in TP53 gene. Clinical implications and family counselling”
2025
·
A. Zavos
, I. Natsiopoulos
, et al.
·
The Breast
Marking of Target Lymph Nodes with carbon suspension in breast cancer patients undergoing neoadjuvant chemotherapy – first results from the AXSANA study (NCT04373655)
2024
·
A. Rief
, S. Hartmann
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Show more works
View as search
Works count:
34
Citation count:
285
H-index:
10
I10-index:
11
Year
Topic
Type
